Propagating prions in fungi and mammals

Molecular Cell

Volumn 14, Issue 5, 2004, Pages 541-552

  Tuite, Mick F ^a   Koloteva Levin, Nadejda ^a  

^a UNIVERSITY OF KENT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; PRION PROTEIN;

AMINO ACID SEQUENCE; CELL FUNCTION; FUNGUS; HUMAN; MAMMAL; MODEL; NONHUMAN; PHENOTYPE; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTEIN TRANSPORT; REVIEW; STRUCTURE ANALYSIS;

AMYLOID; ANIMALS; CELL-FREE SYSTEM; FUNGAL PROTEINS; HUMANS; MAMMALS; MODELS, BIOLOGICAL; PRION DISEASES; PRIONS; PROTEIN FOLDING; PROTEIN STRUCTURE, TERTIARY;

FUNGAL PRIONS; FUNGI; MAMMALIA;

EID: 2942620539     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molcel.2004.05.012     Document Type: Review

References (116)

1. Res in vitro. J. Mol. Biol. 332:2003;47-57
2. Bach S., Talarek N., Andrieu T., Vierfond J.M., Mettey Y., Galons H., Dormont D., Meijer L., Cullin C., Blondel M. Isolation of drugs active against mammalian prions using a yeast-based screening assay. Nat. Biotech. 21:2003;1075-1081
3. Balbirnie M., Grothe R., Eisenberg D.S. An amyloid-forming peptide from the yeast prion Sup35 reveals a dehydrated beta-sheet structure for amyloid. Proc. Natl. Acad. Sci. USA. 98:2001;2375-2380
4. Balguerie A., Dos Reis S., Ritter C., Chaignepain S., Coulary-Salin B., Forge V., Bathany K., Lascu I., Schmitter J.M., Riek R., Saupe S.J. Domain organization and structure-function relationship of the HET-s prion protein of Podospora anserina. EMBO J. 22:2003;2071-2081
5. Barron R.M., Thomson V., Jamieson E., Melton D.W., Ironside J., Will R., Manson J.C. Changing a single amino acid in the N-terminus of murine PrP alters TSE incubation time across three species barriers. EMBO J. 20:2001;5070-5078
6. Sc) into contiguous membranes. EMBO J. 21:2002;1031-1040
7. Baskakov I.V., Legname G., Baldwin M.A., Prusiner S.B., Cohen F.E. Pathway complexity of prion protein assembly into amyloid. J. Biol. Chem. 277:2002;21140-21148
8. Bousset L., Thomson N.H., Radford S.E., Melki R. The yeast prion Ure2p retains its native alpha-helical conformation upon assembly into protein fibrils in vitro. EMBO J. 21:2002;2903-2911
9. Bradley M.E., Edskes H.K., Hong J.Y., Wickner R.B., Liebman S.W. Interactions among prions and prion "strains" in yeast. Proc. Natl. Acad. Sci. USA. 99:2002;16392-16399
10. Bruce M.E. Scrapie strain variation and mutation. Br. Med. Bull. 49:1993;822-838
11. Caughey B. Prion protein conversions. insight into mechanisms, TSE transmission barriers and strains Br. Med. Bull. 66:2003;109-120
12. Caughey B., Kocisko D.A. Prion diseases. a nucleic-acid accomplice? Nature. 425:2003;673-674
13. Chabry J., Caughey B., Chesebro B. Specific inhibition of in vitro formation of protease-resistant prion protein by synthetic peptides. J. Biol. Chem. 273:1998;13203-13207
14. +. Science. 268:1995;880-884
15. Chesebro B. BSE and prions. uncertainties about the agent Science. 279:1998;42-43
16. Chien P., Weissman J.S. Conformational diversity in a yeast prion dictates its seeding specificity. Nature. 410:2001;223-227
17. Collinge J. Prion diseases of humans and animals. Their causes and molecular basis Annu. Rev. Neurosci. 24:2001;519-550
18. Coustou V., Deleu C., Saupe S., Begueret J. The protein product of the het-s heterokaryon incompatibility gene of the fungus Podospora anserina behaves as a prion analog. Proc. Natl. Acad. Sci. USA. 94:1997;9773-9778
19. +] prion in yeast Genetics. 165:2003;23-33
20. +], a novel Sup35-prion variant propagated with non-Gln/Asn oligopeptide repeats in the absence of the chaperone protein Hsp104. Genes Cells. 8:2003;603-618
21. DebBurman S.K., Raymond G.J., Caughey B., Lindquist S. Chaperone-supervised conversion of prion protein to its protease-resistant form. Proc. Natl. Acad. Sci.USA. 94:1997;13938-13943
22. Deleault N.R., Lucassen R.W., Supattapone S. RNA molecules stimulate prion protein conversion. Nature. 425:2003;717-720
23. DePace A.H., Santoso A., Hillner P., Weissman J.S. A critical role for amino-terminal glutamine/asparagine repeats in the formation and propagation of a yeast prion. Cell. 93:1998;1241-1252
24. DePace A.H., Weissman J.S. Origins and kinetic consequences of diversity in Sup35 yeast prion fibers. Nat. Struct. Biol. 9:2002;389-396
25. Derkatch I.L., Chernoff Y.O., Kushnirov V.V., Inge-Vechtomov S.G., Liebman S.W. Genesis and variability of [PSI] prion factors in Saccharomyces cerevisiae. Genetics. 144:1996;1375-1386
26. +] prion in yeast. Curr. Genet. 35:1999;59-67
27. Diaz-Avalos R., Long C., Fontano E., Balbirnie M., Grothe R., Eisenberg D., Caspar D. Cross-beta order and diversity in nanocrystals of an amyloid-forming peptide. J. Mol. Biol. 330:2003;1165-1175
28. - mutation which eliminates the psi factor of Saccharomyces cerevisiae is the result of a missense mutation in the SUP35 gene. Genetics. 137:1994;659-670
29. Donne D.G., Viles J.H., Groth D., Mehlhorn I., James T.L., Cohen F.E., Prusiner S.B., Wright P.E., Dyson H.J. Structure of the recombinant full-length hamster prion protein PrP(29-231). the N terminus is highly flexible Proc. Natl. Acad. Sci. USA. 94:1997;13452-13457
30. Dos Reis S., Coulary-Salin B., Forge V., Lascu I., Begueret J., Saupe S.J. The HET-s prion protein of the filamentous fungus Podospora sparagi aggregates in vitro into amyloid-like fibrils. J. Biol. Chem. 277:2002;5703-5706
31. +] of Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. USA. 97:2000;240-244
32. Flechsig E., Shmerling D., Hegyi I., Raeber A.J., Fischer M., Cozzio A., von Mering C., Aguzzi A., Weissmann C. Prion protein devoid of the octapeptide repeat region restores susceptibility to scrapie in PrP knockout mice. Neuron. 27:2000;399-408
33. Gazit E. Global analysis of tandem aromatic octapeptide repeats. the significance of the aromatic-glycine motif Bioinformatics. 18:2002;880-883
34. Ghosh S. Mechanism of intestinal entry of infectious prion protein in the pathogenesis of variant Creutzfeldt-Jakob disease. Adv. Drug Deliv. Rev. 56:2004;915-920
35. Glover J.R., Lindquist S. Hsp104, Hsp70, and Hsp40. A novel chaperone system that rescues previously aggregated proteins Cell. 94:1998;73-82
36. +, a heritable prion-like factor of S.cerevisiae. Cell. 89:1997;811-819
37. Goldsbury C., Kistler J., Aebi U., Ardvinte T., Cooper G.J. Watching amyloid fibrils grow by time-lapse atomic force microscopy. J. Mol. Biol. 285:1999;33-39
38. Griffith J.S. Self-replication and scrapie. Nature. 215:1967;1043-1044
39. Grimminger V., Richter K., Imhof A., Buchner J., Walter S. The prion curing agent guanidinium chloride specifically inhibits ATP hydrolysis by Hsp104. J. Biol. Chem. 279:2004;7378-7383
40. Gu Y., Verghese S., Mishra R.S., Xu X., Shi Y., Singh N. Mutant prion protein-mediated aggregation of normal prion protein in the endoplasmic reticulum. implications for prion propagation and neurotoxicity J. Neurochem. 84:2003;10-22
41. +] transmission. Genes Cells. 8:2003;925-939
42. Harris D.A. Cell biological studies of the prion protein. Curr. Issues Mol. Biol. 1:1999;65-75
43. C may inhibit prion disease propagation. Brain Res. 993:2003;192-200
44. Hill A.F., Antoniou M., Collinge J. Protease-resistant prion protein produced in vitro lacks detectable infectivity. J. Gen. Virol. 80:1999;11-14
45. Sc accumulation. J. Virol. 72:1998;1153-1159
46. Hornshaw M.P., McDermott J.R., Candy J.M., Lakey J.H. Copper binding to the N-terminal tandem repeat region of mammalian and avian prion protein. structural studies using synthetic peptides Biochem. Biophys. Res. Commun. 214:1995;993-999
47. Jarrett J.T., Lansbury P.T. Seeding "one-dimensional crystallization" of amyloid. a pathogenic mechanism in Alzheimer's disease and scrapie? Cell. 73:1993;1055-1058
48. +] prion propagation and cell growth differently and implicate Hsp40 and tetratricopeptide repeat cochaperones in impairment of. Genetics. 163:2003;495-506
49. Kimura Y., Koitabashi S., Fujita T. Analysis of yeast prion aggregates with amyloid-staining compound in vivo. Cell Struct. Funct. 28:2003;187-193
50. King C.Y., Diaz-Avalos R. Protein-only transmission of three yeast prion strains. Nature. 428:2004;319-323
51. King C.Y., Tittmann P., Gross H., Gebert R., Aebi M., Wuthrich K. Prion-inducing domain 2-114 of yeast Sup35 protein transforms in vitro into amyloid-like filaments. Proc. Natl. Acad. Sci. USA. 94:1997;6618-6622
52. Kocisko D.A., Come J.H., Priola S.A., Chesebro B., Raymond G.J., Lansbury P.T., Caughey B. Cell-free formation of protease-resistant prion protein. Nature. 370:1994;471-474
53. Kocisko D.A., Baron G.S., Rubenstein R., Chen J., Kuizon S., Caughey B. New inhibitors of scrapie-associated prion protein formation in a library of 2000 drugs and natural products. J. Virol. 77:2003;10288-10294
54. Kryndushkin D.S., Smirnov V.N., Ter-Avanesyan M.D., Kushnirov V.V. Increased expression of Hsp40 chaperones, transcriptional factors, and ribosomal protein Rpp0 can cure yeast prions. J. Biol. Chem. 277:2002;23702-23708
55. +] prion aggregates are formed by small Sup35 polymers fragmented by Hsp104. J. Biol. Chem. 278:2003;49636-49643
56. Kundu B., Maiti N.R., Jones E.M., Surewicz K.A., Vanik D.L., Surewicz W.K. Nucleation-dependent conformational conversion of the Y145Stop variant of human prion protein. structural clues for prion propagation Proc. Natl. Acad. Sci. USA. 100:2003;12069-12074
57. Kushnirov V.V., Ter-Avanesyan M.D. Structure and replication of yeast prions. Cell. 94:1998;13-16
58. Lawson V.A., Priola S.A., Wehrly K., Chesebro B. N-terminal truncation of prion protein affects both formation and conformation of abnormal protease-resistant prion protein generated in vitro. J. Biol. Chem. 276:2001;35265-35271
59. Lawson V.A., Priola S.A., Meade-White K., Lawson M., Chesebro B. Flexible N-terminal region of prion protein influences conformation of protease-resistant prion protein isoforms associated with cross-species scrapie infection in vivo and in vitro. J. Biol. Chem. 279:2004;13689-13695
60. Lehmann S., Harris D.A. Blockade of glycosylation promotes acquisition of scrapie-like properties by the prion protein in cultured cells. J. Biol. Chem. 272:1997;21479-21487
61. Li L., Lindquist S. Creating a protein-based element of inheritance. Science. 287:2000;661-664
62. Liu J.J., Lindquist S. Oligopeptide-repeat expansions modulate 'protein-only' inheritance in yeast. Nature. 400:1999;573-576
63. Maddelein M.L., Dos Reis S., Duvezin-Caubet S., Coulary-Salin B., Saupe S.J. Amyloid aggregates of the HET-s prion protein are infectious. Proc. Natl. Acad. Sci. USA. 99:2002;7402-7407
64. Masison D.C., Wickner R.B. Prion-inducing domain of yeast Ure2p and protease resistance of Ure2p in prion-containing cells. Science. 270:1995;93-95
65. Maxson L., Wong C., Herrmann L.M., Caughey B., Baron G.S. A solid-phase assay for identification of modulators of prion protein interactions. Anal. Biochem. 323:2003;54-64
66. McKinley M.P., Bolton D.C., Prusiner S.B. A protease-resistant protein is a structural component of the scrapie prion. Cell. 35:1983;57-62
67. Morgan B.J., Ridout M.S., Ruddock L.W. Models for yeast prions. Biometrics. 59:2003;562-569
68. Moriyama H., Edskes H.K., Wickner R.B. [URE3] prion propagation in Saccharomyces cerevisiae. requirement for chaperone Hsp104 and curing by overexpressed chaperone Ydj1p Mol. Cell. Biol. 20:2000;8916-8922
69. Nazabal A., Dos Reis S., Bonneu M., Saupe S.J., Schmitter J.M. Conformational transition occurring upon amyloid aggregation of the HET-s prion protein of Podospora sparagi analyzed by hydrogen/deuterium exchange and mass spectrometry. Biochemistry. 42:2003;8852-8861
70. Ness F., Ferreira P., Cox B.S., Tuite M.F. Guanidine hydrochloride inhibits the generation of prion "seeds" but not prion protein aggregation in yeast. Mol. Cell. Biol. 22:2002;5593-5605
71. Orr H.T. Beyond the Qs in the polyglutamine diseases. Genes Dev. 15:2001;925-932
72. Osherovich L.Z., Cox B.S., Tuite M.F., Weissman J.S. Dissection and design of yeast prions. PloS Biol. 2:2004;442-451
73. Pan K.M., Baldwin M., Nguyen J., Gasset M., Serban A., Groth D., Mehlhorn I., Huang Z., Fletterick R.J., Cohen F.E., Prusiner S.B. Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proc. Natl. Acad. Sci. USA. 90:1993;10962-10966
74. Parham S.N., Resende C.G., Tuite M.F. Oligopeptide repeats in the yeast protein Sup35p stabilize intermolecular prion interactions. EMBO J. 20:2001;2111-2119
75. Patino M.M., Liu J.J., Glover J.R., Lindquist S. Support for the prion hypothesis for inheritance of a phenotypic trait in yeast. Science. 273:1996;622-626
76. Pauly P.C., Harris D.A. Copper stimulates endocytosis of the prion protein. J. Biol. Chem. 273:1998;33107-33110
77. Paushkin S.V., Kushnirov V.V., Smirnov V.N., Ter-Avanesyan M.D. In vitro propagation of the prion-like state of yeast Sup35 protein. Science. 277:1997;381-383
78. Perutz M.F., Pope B.J., Owen D., Wanker E.E., Scherzinger E. Aggregation of proteins with expanded glutamine and alanine repeats of the glutamine-rich and sparagines-rich domains of Sup35 and of the amyloid beta-peptide of amyloid plaques. Proc. Natl. Acad. Sci. USA. 99:2002;5596-5600
79. Sc formation. Chembiochem. 3:2002;717-725
80. Prusiner S.B. Novel proteinaceous infectious particles cause scrapie. Science. 216:1982;136-144
81. Prusiner S.B. Molecular biology of prion diseases. Science. 252:1991;1515-1522
82. Prusiner S.B., Scott M.R., DeArmond S.J., Cohen F.E. Prion protein biology. Cell. 93:1998;337-348
83. Rhie A., Kirby L., Sayer N., Wellesley R., Disterer P., Sylvester I., Gill A., Hope J., James W., Tahiri-Alaoui A. Characterization of 2′-fluoro-RNA aptamers that bind preferentially to disease-associated conformations of prion protein and inhibit conversion. J. Biol. Chem. 278:2003;39697-39705
84. Riek R., Hornemann S., Wider G., Glockshuber R., Wuthrich K. NMR characterization of the full-length recombinant murine prion protein, mPrP(23-231). FEBS Lett.s. 413:1997;282-288
85. Ripaud L., Maillet L., Cullin C. The mechanisms of [URE3] prion elimination demonstrate that large aggregates of Ure2p are dead-end products. EMBO J. 22:2003;5251-5259
86. Rochet J.C., Lansbury P.T. Amyloid fibrillogenesis. themes and variations Curr. Opin. Struct. Biol. 10:2000;60-68
87. Saborio G.P., Permanne B., Soto C. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature. 411:2001;810-813
88. Saborio G.P., Soto C., Kascsak R.J., Levy E., Kascsak R., Harris D.A., Frangione B. Cell-lysate conversion of prion protein into its protease-resistant isoform suggests the participation of a cellular chaperone. Biochem. Biophys. Res. Commun. 258:1999;470-475
89. Saupe S.J. New anti-prion drugs make yeast blush. Trends Biotechnol. 21:2003;516-519
90. Scheibel T., Lindquist S.L. The role of conformational flexibility in prion propagation and maintenance for Sup35p. Nat. Struct. Biol. 8:2001;958-962
91. Scheibel T., Kowal A.S., Bloom J.D., Lindquist S.L. Bidirectional amyloid fiber growth for a yeast prion determinant. Curr. Biol. 11:2001;366-369
92. Schirmer E.C., Lindquist S. Interactions of the chaperone Hsp104 with yeast Sup35 and mammalian PrP. Proc. Natl. Acad. Sci. USA. 94:1997;13932-13937
93. Schlumpberger M., Prusiner S.B., Herskowitz I. Induction of distinct [URE3] yeast prion strains. Mol. Cell. Biol. 21:2001;7035-7046
94. Serio T.R., Cashikar A.G., Kowal A.S., Sawicki G.J., Moslehi J.J., Serpell L., Arnsdorf M.F., Lindquist S.L. Nucleated conformational conversion and the replication of conformational information by a prion determinant. Science. 289:2000;1317-1321
95. Sondheimer N., Lindquist S. Rnq1. an epigenetic modifier of protein function in yeast Mol. Cell. 5:2000;163-172
96. +] prion. EMBO J. 20:2001;2435-2442
97. Soto C., Kascsak R.J., Saborio J.P., Aucouturier P., Wisniewski T., Prelli F., Kascsak R., Mendez E., Harris D.A., Ironside J. Reversion of prion protein conformational changes by synthetic beta-sheet breaker peptides. Lancet. 355:2000;192-197
98. +] factor by in vitro- converted Sup35 protein Science. 289:2000;595-599
99. Stockel J., Safar J., Wallace A.C., Cohen F.E., Prusiner S.B. Prion protein selectively binds copper(II) ions. Biochemistry. 37:1998;7185-7193
100. Tanaka M., Chien P., Naber N., Cooke R., Weissman J.S. Conformational variations in an infectious protein determine prion strain differences. Nature. 428:2004;323-328
101. Taylor K.L., Cheng N., Williams R.W., Steven A.C., Wickner R.B. Prion domain initiation of amyloid formation in vitro from native Ure2p. Science. 283:1999;1339-1343
102. Telling G.C., Scott M., Mastrianni J., Gabizon R., Torchia M., Cohen F.E., DeArmond S.J., Prusiner S.B. Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein. Cell. 83:1995;79-90
103. Thual C., Komar A.A., Bousset L., Fernandez-Bellot E., Cullin C., Melki R. Structural characterization of Saccharomyces cerevisiae prion-like protein Ure2. J. Biol. Chem. 274:1999;13666-13674
104. Tuite M.F. Yeast prions and their prion-forming domain. Cell. 100:2000;289-292
105. Tuite M.F., Cox B.S. Propagation of yeast prions. Nat. Rev. Mol. Cell Biol. 4:2003;878-890
106. Uptain S.M., Lindquist S. Prions as protein-based genetic elements. Annu. Rev. Microbiol. 56:2002;703-741
107. Vogtherr M., Grimme S., Elshorst B., Jacobs D.M., Fiebig K., Griesinger C., Zahn R. Antimalarial drug quinacrine binds to C-terminal helix of cellular prion protein. J. Med. Chem. 46:2003;3563-3564
108. Wegrzyn R.D., Bapat K., Newnam G.P., Zink A.D., Chernoff Y.O. Mechanism of prion loss after Hsp104 inactivation in yeast. Mol. Cell. Biol. 21:2001;4656-4669
109. Weissmann C. Molecular genetics of transmissible spongiform encephalopathies. J. Biol. Chem. 274:1999;3-6
110. Weissmann, C., Raeber, A.J., Shmerling, D., Aguzzi, A., and Manson, J.C. (1999). Knockouts, transgenics and transplants in prion research. In Prion Biology and Diseases, S.B. Prusiner, ed. (New York, Cold Spring Harbor Laboratory Press), pp. 273-305.
111. Wickner R.B. [URE3] as an altered URE2 protein. evidence for a prion analog in Saccharomyces cerevisiae Science. 264:1994;566-569
112. Wickner R.B., Edskes H.K., Roberts B.T., Pierce M., Baxa U. Prions of yeast as epigenetic phenomena. high protein "copy number" inducing protein "silencing Adv. Genet. 46:2002;485-525
113. Sc. Traffic. 4:2003;313-322
114. Yadavalli R., Guttmann R.P., Seward T., A.P C., Williamson R.A., Telling G.C. Calpain-dependent endoproteolytic cleavage of PrPSc modulates scrapie prion propagation. J. Biol. Chem. 279:2004;. in press
115. Yamanaka K., Okubo Y., Suzaki T., Ogura T. Analysis of the two p97/VCP/Cdc48p proteins of Caenorhabditis elegans and their suppression of polyglutamine-induced protein aggregation. J. Struct. Biol. 146:2004;242-250
116. +] and. Mol. Microbiol. 39:2001;37-46